• 1
    Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implication for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996; 93:1624 9.
  • 2
    Pittoni V & Isenberg DA. Apoptosis and antiphospholipid antibodies. Semin Arthritis Rheum 1998; 28:163 78.
  • 3
    Le Deist F, Emile JF, Rieux-Laucat F, Benkerrou M, Roberts I, Brousse N, Fischer A. Clinical immunological and pathological consequences of Fas-deficient conditions. Lancet 1996; 348:719 23.
  • 4
    Rieux Lacat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fisher A, De Villartay JP. Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1996; 268:1347 9.
  • 5
    Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkis NA, Nagata S. Lymphoproliferation disorder in mice explained by defect in Fas antigen that mediates apoptosis. Nature 1992; 356:314 7.
  • 6
    Osborne BA. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 1996; 8:245 54.
  • 7
    Thomas N & Bell PA. Glucocorticoid induced cell size changes and nuclear fragility in rat thymocytes. Mol Cell Endocrinol 1981; 22:41 84.
  • 8
    Ohyama H, Yamada T, Watabane I. Cell Volume reduction associated with interphase death in rat thymocytes. Radiat Res 1981; 85:333 9.
  • 9
    Godman GC, Miranda AF, Deitch AD, Tanenbaum SW. Action of cytochalasin D on cells of established lines. Zeiois and movement of cell surface. J Cell Biol 1975; 64:644 67.
  • 10
    Levy RA. Clinical manifestation of the aPL syndrome. Lupus 1996; 5:393 7.
  • 11
    Oosting JD, Derksen RHWM, Bobbink IWG, Hackengt TM, Bouma BN, De Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C and protein S—an explanation for their pathogenic mechanism? Blood 1993; 81:2618 25.
  • 12
    McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120 4.
  • 13
    Cabiedes J, Cabral AR, Alarcon Segovia D. Clinical manifestations of the antiphospholipid syndrome associate more strongly with anti-β2-glycoprotein I antibodies than with antiphospholipid antibodies. J Rheumatol 1995; 22:1899 906.
  • 14
    Roubey RAS, Eisenberg R, Harper MF, Winfield JB. ‘Anticardiolipin’ antibodies recognize β2-glycoprotein I in the absence of phospholipid. Importance of AG density and bivalent binding. J Immunol 1995; 154:954 60.
  • 15
    Pengo V, Basiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 73:29 34.
  • 16
    Matsura E, Igarashi J, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457 62.
  • 17
    Devaux FP & Zachowski A. Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipids 1994; 73:107 20.
  • 18
    Williamson P & Schlegel RA. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol Memb Biol 1994; 11:199 216.
  • 19
    Vermes I, Haanen C, Steffens-Nakken H, Reuteligsperger C. A novel assay for apoptosis-flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescent labelled Annexin V. J Immunol Methods 1995; 184:39 51.
  • 20
    Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179:1317 30.
  • 21
    Aupeix K, Toti F, Satta N, Bichoff P, Freyssinet JM. Oyxsterols induce membrane procoagulant activity in monocyte THP-1 cells. Biochem J 1996; 314:1027 33.
  • 22
    Ravirajan CT, Harmer I, McNally T, Hohmann A, Mackworth-Young CG, Isenberg DA. Phospholipid binding specifities and idiotype expression of hybridoma derived monoclonal autoantibodies from splenic cells of patients with systemic lupus erythematosus. Ann Rheum Dis 1995; 54:471 6.
  • 23
    Menon S, Rahman MAA, Ravirajan CT et al. The production, binding characteristic and sequence analysis of four human IgG monoclonal antiphospholipid antibodies. J Autoimmun 1997; 10:43 57.
  • 24
    Ravirajan CT, Kalsi J, Winska Wiloch H et al. Antigen-binding diversity of human hybridoma autoantibodies derived from splenocytes of patients with SLE. Lupus 1992; 1:157 65.
  • 25
    Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 1992; 86:83 87.
  • 26
    Caronti B, Pittoni V, Palladini G, Valesini G. Anti-β2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 1998; 156:211 9.
  • 27
    McNally T, Mackie IJ, Isenberg DA, Machin SJ. Immunoelectrophoresis and ELISA techniques for assay of plasma β2-glycoprotein I and the influence of plasma lipids. Thromb Res 1993; 72:275 86.
  • 28
    Kšnig K, Liang H, Berns MW, Tromberg BJ. Cell damage by near-IR microbeams. Nature 1995; 337:20 21.
  • 29
    Galea-Lauri J, Richardson AJ, Latchman DS, Katz DR. Increased heat shock protein 90 (hsp 90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-α and cycloheximide. J Immunol 1996; 157:4109 18.
  • 30
    Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A. Flow cytometric analysis of early phases of apoptosis by cellular and nuclear techniques. Cytometry 1996; 24:106 15.
  • 31
    Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152:3685 92.
  • 32
    Richardson BC. Monocyte apoptosis in patients with active lupus. Arthritis Rheum 1996; 39:1432 4.
  • 33
    Inanc M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA. Anti-β2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 1998; 37:1089 94.
  • 34
    El Kadi HS, Keil LB, DeBari VA. Analytical and clinical relationship between human IgG antibodies to β2-glycoprotein I and anticardiolipin antibodies. J Rheumatol 1995; 22:2233 7.
  • 35
    Del Papa N, Sheng YH, Raschi E et al. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-β2-glycoprotein I antibodies. J Immunol 1998; 160:5572 8.
  • 36
    Price BE, Rauch J, Shia MA et al. Anti-phospholipid antibodies bind to apoptotic but not viable thymocytes in a beta2-glycoprotein I-dependent manner. J Immunol 1996; 157:2201 8.
  • 37
    Manfredi AA, Rovere P, Heltai S, Galati G, Nebbia G, Tincani A, Balestrieri G, Sabbadini MG. Apoptotic cell clearance in systemic lupus erythematosus. Role of β2-glycoprotein I. Arthritis Rheum 1997; 41:215 23.
  • 38
    Frankfurt OS, Robb JA, Sugarbaker EV, Villa L. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 1996; 226:387 97.
  • 39
    Pradhan D, Krahling S, Williamson P, Schlegel RA. Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 1997; 8:767 78.
  • 40
    Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leuk Biol 1992; 52:269 73.
  • 41
    Manfredi AA, Rovere P, Galati G et al. Apoptotic cell clearance in systemic lupus erythematosus. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1997; 41:205 14.
  • 42
    Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75:281 9.
  • 43
    Amengual O, Atsumi T, Khamashta MA, Hughes GR. The role of tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Res 1998; 79:276 81.
  • 44
    Pittoni V, Ravirajan CT, Isenberg DA. Anti-phospholipid and anti-DNA human monoclonal antibodies bind monoblastoid cell line U937 undergoing apoptosis. Br J Rheumatol 1998; 37 (S1):73(Abstr.).
  • 45
    Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188:387 92.
  • 46
    Rovere P, Sabbadini MG, Vallinoto C et al. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies. Arthritis Rheum 1999; 42:1412 20.